食品科学 ›› 2021, Vol. 42 ›› Issue (5): 129-136.doi: 10.7506/spkx1002-6630-20200105-043

• 营养卫生 • 上一篇    下一篇

榆干离褶伞溶栓酶对脂多糖诱导的血管内皮细胞损伤的保护作用

耿超,卫莹,沈明花   

  1. (延边大学医学院,吉林 延吉 133002)
  • 出版日期:2021-03-15 发布日期:2021-03-29
  • 基金资助:
    国家自然科学基金地区科学基金项目(81760031)

Protective Effect of Lyophyllum ulmarium Fibrinolytic Enzyme on Endothelial Cells from Injury Induced by Lipopolysaccharide

GENG Chao, WEI Ying, SHEN Minghua   

  1. (Medical College, Yanbian University, Yanji 133002, China)
  • Online:2021-03-15 Published:2021-03-29

摘要: 目的:探讨榆干离褶伞溶栓酶对脂多糖(lipopolysaccharide,LPS)诱导的血管内皮细胞炎性损伤的保护作用。方法:以LPS诱导人脐静脉内皮细胞(human umbilical vein endothelial cells,HUVEC)炎性损伤。将HUVEC分为空白对照组、模型组和榆干离褶伞溶栓酶(Lyophyllum ulmarium fibrinolytic enzyme,LUFE)低、中、高剂量组。采用噻唑蓝法测定HUVEC存活率,通过酶联免疫吸附测试法检测细胞上清液乳酸脱氢酶(lactate dehydrogenase,LDH)、肿瘤坏死因子α(tumor necrosis factor α,TNF-α)、白介素6(interleukin 6,IL-6)、E-选择素和单核细胞趋化因子1(monocyte chemoattractant protein 1,MCP-1)水平。流式细胞术检测细胞间黏附分子1(intercellular cell adhesion molecule 1,ICAM-1)表达水平,采用Hoechst染色法观察HUVEC与人急性单核细胞白血病细胞系(human acute monocytic leukemia cell line-1,THP-1)的黏附作用。用蛋白印迹实验检测HUVEC的Toll样受体4(toll-like receptor 4,TLR4)、丝裂原活化蛋白激酶(mitogen-activated protein kinase,MAPK)以及核因子-κB(nuclear factor κB,NF-κB)通路中主要蛋白(髓样分化因子88(myeloid differentiation factor 88,MyD88)、转化生长因子β激活激酶1(transforming growth factor β activated kinase 1,TAK1)、磷酸化TAK1(phosphorylated TAK1,p-TAK1))的表达和活化情况。结果:LUFE能够抑制LPS所诱导的HUVEC培养上清液LDH、TNF-α、IL-6、E-选择素和MCP-1水平的升高,降低细胞ICAM-1表达水平并减弱HUVEC与THP-1的黏附作用。与模型组比较,LUFE各剂量组TLR4、MyD88、p-TAK1/TAK1、磷酸化c-Jun氨基末端激酶(phosphorylated c-Jun N-terminal kinase,p-JNK)/JNK、p-p38/p38、p-NF-κB/NF-κB水平显著降低(P<0.05)。结论:LUFE对血管内皮细胞的炎性损伤具有保护作用,其作用机制可能是通过抑制TLR4/MyD88/TAK1/NF-κB信号通路及MAPK通路,进而降低炎症因子水平,从而保护血管内皮细胞。

关键词: 榆干离褶伞溶栓酶;脂多糖;血管内皮细胞;炎症

Abstract: Objective: To investigate the protective effect of Lyophyllum ulmarium fibrinolytic enzyme (LUFE) on inflammatory injury induced by lipopolysaccharide (LPS) in vascular endothelial cells. Methods: An in vitro inflammation model was created by stimulating human umbilical vein endothelial cells (HUVEC) with LPS. The HUVEC were divided into five groups including control, model and low-, medium- and high-dose LUFE groups. The survival rate of HUVEC was determined by MTT assay. The levels of lactate dehydrogenase (LDH) activity, tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), E-selectin and monocyte chemoattractant protein 1 (MCP-1) in the cell culture supernatant were investigated by enzyme-linked immunosorbent assay (ELISA). The Hoechst method was adopted to observe the adhesion between HUVEC and human acute monocytic leukemia cell line-1 (THP-1). The expression of intercellular cell adhesion molecule 1 (ICAM1) in HUVEC was detected by flow cytometry. Western blot assay was used to detect the expression and activation of toll-like receptor 4 (TLR4), mitogen-activated protein kinase (MAPK) and the major proteins involved in the nuclear factor κB (NF-κB) signaling pathway including myeloid differentiation factor 88 (MyD88), transforming growth factor β activated kinase 1 (TAK1) and phosphorylated TAK1 (p-TAK1). Results: LUFE inhibited the LPS-induced increase in the levels of LDH, TNF-α, IL-6, E-selectin and MCP-1 in the culture supernatant of HUVEC, decreased the expression level of ICAM-1, and reduced the adhesion of HUVEC to THP-1. Compared with the model group, the levels of TLR4 and MyD88, p-TAK1/TAK1 ratio, the ratio of phosphorylated c-Jun N-terminal kinase (p-JNK) to JNK, the ratio of phosphorylated protein-38 (p-p38) to p38, and the ratio of phosphorylated NF-κB (p-NF-κB) to NF-κB in all three LUFE treatment groups were significantly reduced (P < 0.05). Conclusion: LUFE has a protective effect on inflammatory injury in HUVEC, and its underlying mechanism may be though inhibiting the TLR4/MyD88/TAK1/NF-κB signaling pathway and the MAPK signaling pathway and thereby reducing the level of inflammatory factors.

Key words: Lyophyllum ulmarium fibrinolytic enzyme; lipopolysaccharide; endothelial cell; inflammation

中图分类号: